Journal Title：Oncology And Therapy

oncology And Therapy Is An International, Peer Reviewed, Rapid-publication (peer Review In 2 Weeks, Published 3–4 Weeks From Acceptance) Journal Dedicated To The Publication Of High-quality Pre-clinical, Clinical (all Phases), Observational, Real-world, And Health Outcomes Research Around The Discovery, Development, And Use Of Therapeutics And Interventions (including Devices) Across All Therapeutic Areas. Studies Relating To Diagnostics And Diagnosis, Pharmacoeconomics, Public Health, Epidemiology, Quality Of Life, And Patient Care, Management, And Education Are Also Encouraged.

the Journal Is Of Interest To A Broad Audience Of Healthcare Professionals And Publishes Original Research, Reviews, Communications And Letters. The Journal Is Read By A Global Audience And Receives Submissions From All Over The World. Oncology And Therapy Will Consider All Scientifically Sound Research Be It Positive, Confirmatory Or Negative Data. Submissions Are Welcomed Whether They Relate To An International And/or A Country-specific Audience, Something That Is Crucially Important When Researchers Are Trying To Target More Specific Patient Populations. This Inclusive Approach Allows The Journal To Assist In The Dissemination Of All Scientifically And Ethically Sound Research.

《腫瘤學與治療》是一本國際性、同行評審、快速出版的期刊（同行評審在2周內，自接受之日起3-4周內出版），致力于圍繞所有治療領域的治療和干預措施（包括設備）的發現、開發和使用，發表高質量的臨床前、臨床（所有階段）、觀察、現實世界和健康結果研究。還鼓勵與診斷和診斷、藥物經濟學、公共衛生、流行病學、生活質量以及患者護理、管理和教育相關的研究。

該雜志受到廣大醫療保健專業人士的關注，并發表原創研究、評論、通訊和信件。該雜志由全球讀者閱讀，并收到來自世界各地的投稿。腫瘤學和治療將考慮所有科學合理的研究，無論是積極的、證實的還是消極的數據。歡迎提交意見，無論是針對國際和/或特定國家的受眾，這在研究人員試圖針對更特定的患者群體時至關重要。這種包容性的方法使該雜志能夠協助傳播所有科學和倫理上合理的研究。

Oncology And Therapy由Adis, Springer Healthcare出版商出版，收稿方向涵蓋ONCOLOGY全領域，平均審稿速度 6 Weeks ，影響因子指數3.2，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。